An open-label evaluation of safety and tolerability of coformulated bictegravir/emtricitabine/tenofovir alafenamide for post-exposure prophylaxis following potential exposure to human immunodeficiency virus-1-Reference-Cited by-同舟云学术

An open-label evaluation of safety and tolerability of coformulated bictegravir/emtricitabine/tenofovir alafenamide for post-exposure prophylaxis following potential exposure to human immunodeficiency virus-1

Published:2022-12-28 Issue: Volume:Publish Ahead of Print Page:
ISSN:2542-5641
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Liu An,Xin Ruolei,Zhang Hongwei,Dai Lili,Wu Ruojun (Esther),Wang Xi,Li Aixin,Hua Wei,Li Jianwei,Shao Ying,Gao Yue,Wang Zhangli,Ye Jiangzhu,bu dou re xi ti Gulimila A,Li Zaicun,Sun Lijun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference26 articles.

1. UK guideline for the use of HIV post-exposure prophylaxis following sexual exposure, 2015;Cresswell;Int J STD AIDS,2016

2. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers);Beekmann;Infect Dis Clin North Am,2014

3. Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment;Tsai;J Virol,1998

4. Effects of initiation of 3’-azido,3’-deoxythymidine (zidovudine) treatment at different times after infection of rhesus monkeys with simian immunodeficiency virus;Martin;J Infect Dis,1993

5. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group;Connor;N Engl J Med,1994

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coformulated Bictegravir/Emtricitabine/Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Assault: A Retrospective Real-World Study;Open Forum Infectious Diseases;2024-07-25

2. Safety and adherence of bictegravir/emtricitabine/tenofovir alafenamide for HIV post-exposure prophylaxis among adults in Guiyang China: a prospective cohort study;BMC Infectious Diseases;2024-06-06

3. Pre- and Post-Exposure Prophylaxis for HIV in Patients Taking Anti-Seizure Medications;Epilepsy Currents;2024-05-28

4. Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions;The Lancet HIV;2023-12

5. Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment?;HIV/AIDS - Research and Palliative Care;2023-11